Instagram tests a reposts feature
Some users have reported seeing the feature on their accounts, with one noting that users will be able to repost their own content in addition to other users' posts.
Of course, not everyone will be on board if Instagram decides to roll out the change officially, especially since it would add yet another content format to a platform already overcrowded with posts, Stories, Reels, Notes, DMs, ads, and more.
On the other hand, some people will welcome the change since it will allow them to share and amplify interesting content like they already do on other platforms.
Although you can currently share someone's post in your Story, this upcoming repost functionality will let you reshare the post in Instagram's Feed. In addition, some people currently use workarounds and third-party apps to repost content, so an official reshare feature would get rid of the need to find alternatives.
As for creators, the repost functionality could be a way for them to boost their reach and discoverability. Plus, Instagram is flooded with reposted memes and photos that often don't credit original posters, so the addition of a repost feature could help ensure that creators receive credit when their content is shared widely.
It makes sense for Instagram to introduce the ability to repost, especially since the format has been adopted by other social networks like Threads and TikTok. It's worth noting that reposts were popularized by Twitter's introduction of the 'Retweet' feature back in 2009.
As with any other test feature, it's unknown when or if Instagram plans to release its repost functionality to all users.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Meet the first batch of VCs set to judge Startup Battlefield 200 at TechCrunch Disrupt 2025
From Dropbox to Cloudflare, Startup Battlefield alumni have redefined industries. Who will win $100,000 and the spotlight this year? Startup Battlefield 200 is the crown jewel of TechCrunch Disrupt — and this year's competition promises to be unforgettable. From thousands of applicants, only the top 20 will take the Stage at Disrupt 2025 (October 27–29, San Francisco) to pitch their vision to panels of top-tier VCs in front of a live audience. Every contender is chasing game-changing impact — and we're here for the drama, the breakthroughs, and the big reveals. We're thrilled to announce our first wave of judges who will put these startups to the test with rigorous, no-holds-barred Q&A. Their candid feedback offers a rare window into how world-class investors size up a company — what excites them, what concerns them, and what makes them want to take the next meeting. Winning Startup Battlefield has launched companies like Dropbox, Mint, Vurb, and Cloudflare into the spotlight — and with a $100,000 equity-free prize on the line, the next big name could be born on the Disrupt Stage this October. Don't miss this high-stakes startup pitch-off on a global stage. Learn from emerging founders what it takes to deliver a winning pitch, and hear directly from the investors judging the contenders. Register now for Regular Bird savings. First look: Meet the VCs taking the judges' seats Here are the first five VCs ready to help crown the Startup Battlefield 2025 champion — with more top investors to come soon. Philip Clark, Investor, Thrive Capital Philip Clark is an investor at Thrive Capital, where he has partnered with leading software and hardware companies that are engineering breakthrough advancements in AI and robotics, including Anduril, Cursor, Neuralink, Physical Intelligence, and Wiz. He previously invested at Bridgewater. Philip graduated from Stanford with degrees in Computer Science and Management Science and Engineering. He continues to advise the Hoover Institution on various topics in emerging technologies. Madison Faulkner, Partner, NEA Madison Faulkner is a partner at NEA investing in early-stage data, infrastructure, developer tools, data science, and AI, and she also leads the data and AI platform internally for improved investment decision-making. Across her investing career, she has worked with startups including World Labs, Factory, Ceramic, Metabase, Datafold, Delphina, Mindtrip, Fixify, and others. Prior to investing, Madison was head of data science and machine learning at a growth startup, Thrasio, Head of data science at Greycroft, and led a data science team at Facebook focused on the ad auction and deep learning with FAIR. Madison received a BS in Engineering from Stanford and grew up in Colorado performing in rodeos. Leslie Feinzaig, Founder & General Partner, Graham & Walker VC Leslie Feinzaig is the founder and general partner at Graham & Walker, an early-stage venture fund backing extraordinary founders and ideas that break the mold, whose mission is to change the face of public markets by backing a new guard of founders and CEOs. Prior to launching the fund, Ms. Feinzaig was a 2x startup exec with 8- and 10-figure exits who started her career under the tutelage of HBS Professor Clayton Christensen, author of the seminal theory of disruptive innovation. Ilya Kirnos, Founding Partner & CTO, Signalfire Ilya Kirnos is the co-founder, managing partner, and CTO of ~$3 billion AUM early-stage venture firm SignalFire. He leads the development of SignalFire's in-house Beacon AI data platform, which he's been building for a decade with the firm's team of AI PhDs, engineers, and data scientists. Beacon tracks more than 660 million employees and 80 million companies to guide the fund's investing by surfacing high-quality founders and fast-growing companies, and assists its portfolio companies with recruiting and customer acquisition. As an investor, Ilya focuses on backing seed to Series B companies in enterprise infrastructure and developer tools. He supports highly technical startups in SignalFire's portfolio, including Horizon3 (autonomous pen-testing), OneSignal (notification infrastructure), and PlanetScale (scalable databases). Doug Pepper, Partner, ICONIQ Doug Pepper is a general partner at ICONIQ Growth. He joined ICONIQ Growth in 2019. Doug has helped lead ICONIQ Growth's investments in Airtable, Guild Education, Reify, and others. Prior to joining ICONIQ Growth, Doug was a managing director at Shasta Ventures, a premier early-stage venture capital firm. Previously, he was a general partner at InterWest Partners for 15 years, where he was the first investor in Marketo and served on its board of directors for 10 years. He began his career working at Goldman Sachs and Register now to join the pitch-off action in October TechCrunch Disrupt 2025 marks 20 years as the launchpad for tech innovation. The startup landscape has evolved, but Disrupt remains the place where industry leaders shape the future. From invaluable sessions and game-changing connections to Startup Battlefield, it all happens here this October. Lock in your ticket at low rates now. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 minutes ago
- Yahoo
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025
Register for the three-day event here FRENCHTOWN, NJ / / August 15, 2025 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced its companies will present at the Webull Corporate Connect Webinar Series: Biotech/MedTech being held virtually on August 19-21, 2025. The event will feature three days of presentations from participating companies and interactive Q&A sessions. The schedule of presenting companies is: Tuesday, August 19th 2:00 PM ET: Akari Therapeutics, Plc (NASDAQ:AKTX) 2:20 PM ET: Senti Biosciences, Inc. (NASDAQ:SNTI) 2:40 PM ET: CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Wednesday, August 20th 2:00 PM ET: Moleculin Biotech, Inc. (NASDAQ:MBRX) 2:20 PM ET: GRI Bio, Inc. (NASDAQ:GRI) 2:40 PM ET: AIM ImmunoTech, Inc. (NYSE American:AIM) Thursday, August 21st 2:00 PM ET: enVVeno Medical Corporation (NASDAQ:NVNO) 2:20 PM ET: Autonomix Medical, Inc. (NASDAQ:AMIX) 2:40 PM ET: Nuwellis, Inc. (NASDAQ:NUWE) All investors and interested parties can register for the event and access the schedule of participating companies here. JTC Team is a paid consultant to the participating companies. JTC Team is an investor relations and corporate communications firm. Any content included in this release shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies' websites and the SEC website for the latest information and filings on each company. About JTC Team JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit or connect with the company on X and LinkedIn. Contact: Jenene ThomasJTC Team, LLCT: +1 (908) 824-0775jtc@ SOURCE: JTC Team, LLC View the original press release on ACCESS Newswire
Yahoo
3 minutes ago
- Yahoo
Is Quantum Computing Stock a Buy, Sell, or Hold After Q2 Earnings?
Quantum Computing (QUBT) stock is trading down today after its Q2 2025 results, which showed revenue declining 67% year-over-year to $61,000 and losses expanding to $0.26 per share. Operating expenses for the quantum computing startup more than doubled to $10.2 million compared to the previous year, highlighting the company's aggressive investment in growth initiatives despite minimal current revenue generation. The bottom-line results were worse than expected, with the Wall Street consensus calling for a loss of just $0.06 per share. As a result, QUBT is off about 1.9% in the early going, extending a recent slump beneath its bearishly crossed 20-day and 50-day moving averages. More News from Barchart UnitedHealth Stock Soars as Warren Buffett's Berkshire Hathaway Discloses $1.57B Stake Palantir CEO Alex Karp Sees More Gains Ahead With America-Focused Growth Strategy, Calls U.S. The 'Leader of the Free World' Lucid Motors Is Caught in a Tariff Trap. Is LCID Stock More Likely to Hit $1 or $7 in 2025? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! While QUBT has soared a staggering 2,300% over the past 52 weeks, the quantum computing stock's momentum has slowed considerably in 2025. The stock is underperforming the broader equities market so far this year, down roughly 10% for the period. Highlights from QUBT's Q2 Earnings During the quarter, Quantum Computing strengthened its financial position through a $188 million private placement, resulting in a robust cash balance of $348.8 million. This should provide some crucial runway for their development plans. Notable operational achievements include the completion of their quantum photonic chip foundry in Arizona and securing strategic orders from prestigious institutions like Delft University of Technology and a major automotive manufacturer, demonstrating growing market acceptance of their technology. QUBT's commercial momentum is evidenced by recent contract wins, including a NIST award and an order from a Fortune 500 defense contractor for their TFLN photonic technology. The company has also expanded its reach through strategic partnerships, including a NASA subcontract worth up to $406,478 for quantum-based atmospheric sensing applications, while key leadership changes, such as the appointment of Dr. Yuping Huang as interim CEO, aim to further strengthen commercialization efforts. Should You Buy the Dip in QUBT Stock? From a trading perspective, QUBT's recent inclusion in the Russell 3000 and Russell 2000 indexes has increased its visibility among institutional investors, and effectively broadened their shareholder base. Fundamentally, QUBT's differentiated strategy of operating at room temperature using entropy quantum computing sets them apart in the competitive landscape. That said, the stock's extremely high price-to-sales ratio raises serious valuation concerns. While QUBT shows promising signs of commercial traction, particularly in quantum sensing, cybersecurity, and artificial intelligence (AI) applications, the significant gap between revenue and expenses presents a substantial challenge. The company's future success hinges on their ability to accelerate revenue growth significantly, as QUBT's current financial metrics indicate an increasingly urgent need to convert technological achievements into sustainable commercial results. With only 3 analysts in coverage, QUBT has a consensus rating of 'Hold' - down from 'Moderate Buy' two months ago - and an average price target of $18.50, about 20% north of Thursday's close. This article was created with the support of automated content tools from our partners at Together, our financial data and AI solutions help us to deliver more informed market headline analysis to readers faster than ever. On the date of publication, Elizabeth H. Volk did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
